Amedisys Insider Bruce D. Perkins Reports Small Gift of Shares

Rhea-AI Filing Summary

Amedisys Inc. (AMED) – Form 4 filing overview

Director Bruce D. Perkins reported one transaction dated 07/01/2025. Using transaction code “G” (gift), Perkins transferred 105 shares of Amedisys common stock at a stated price of $0. Following the gift, the director’s direct beneficial ownership stands at 23,992 shares.

The filing does not disclose any derivative security activity and contains no additional explanatory remarks beyond the standard signature block.

• Size of transaction: ~0.4 % of the director’s post-transaction holdings
• Insider relationship: Director (non-executive)
• Ownership form: Direct

No other material financial data, earnings information, or strategic commentary is included in this short Form 4.

Insights

Securities Analyst

TL;DR: Small, non-monetary gift of 105 AMED shares; immaterial to company valuation.

The transaction is coded “G,” indicating a gift rather than an open-market sale. With only 105 shares transferred—roughly 0.4 % of the insider’s 24 k-share position—the filing does not suggest bearish sentiment or raise liquidity concerns. There is no cash consideration and no derivative involvement, so the event has negligible impact on float, insider ownership trends, or valuation models. I classify this as routine compliance reporting.

Corporate Governance Expert

TL;DR: Routine insider gift; governance signal neutral.

Gifts are normally made for estate or charitable planning and do not imply strategic intent. Perkins remains well above typical ownership guidelines for directors, maintaining nearly 24 k shares. The absence of multiple transactions or derivative hedges reinforces the neutral signal. From a governance standpoint, no red flags or positive catalysts emerge.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

PERKINS BRUCE D

(Last) (First) (Middle)

3854 AMERICAN WAY, SUITE A

(Street)

BATON ROUGE LA 70816

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AMEDISYS INC [ AMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/01/2025		G		105	D	$0	23,992	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	Jennifer Guckert Griffin, pursuant to a power of attorney	07/07/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Amedisys (AMED) shares did Director Bruce D. Perkins transfer?

Perkins gifted 105 common shares on 07/01/2025.

What is the director’s remaining ownership after the transaction?

Following the gift, Perkins directly owns 23,992 AMED shares.

Was the transaction an open-market sale or purchase?

No. It was coded “G” for gift, indicating no market sale or purchase.

Did the Form 4 report any derivative security activity?

No derivative securities were acquired, disposed of, or held according to the filing.

Does this Form 4 filing materially affect Amedisys’ share count?

No. The 105-share gift is immaterial relative to Amedisys’ total outstanding shares.